Walgreens Boots Alliance (WBA) Set to Announce Quarterly Earnings on Thursday (2024)

Posted by MarketBeat News on Jun 25th, 2024

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Thursday, June 27th. Analysts expect the company to announce earnings of $0.68 per share for the quarter. Walgreens Boots Alliance has set its FY24 guidance at $3.20-3.35 EPS and its FY 2024 guidance at 3.200-3.350 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.16 EPS. On average, analysts expect Walgreens Boots Alliance to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $15.91 on Tuesday. The firm has a market cap of $13.73 billion, a PE ratio of -2.27, a PEG ratio of 0.99 and a beta of 0.78. The firm has a fifty day moving average of $16.80 and a 200 day moving average of $20.41. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance has a one year low of $14.62 and a one year high of $31.88.

Walgreens Boots Alliance Announces Dividend

Want More Great Investing Ideas?

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 6.29%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Insider Activity at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the business’s stock in a transaction on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on WBA. UBS Group lowered their target price on shares of Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating on the stock in a research note on Monday. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Morgan Stanley lowered their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating on the stock in a research note on Friday, May 31st. Evercore ISI lowered their target price on shares of Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating on the stock in a research note on Monday, June 3rd. Finally, Truist Financial reissued a “hold” rating and set a $25.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $23.07.

Read Our Latest Report on Walgreens Boots Alliance

About Walgreens Boots Alliance

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.